Sunnaas Hospital Report issue

Academic/Hospital Phase 1 Phase 4

Organization Overview

First Clinical Trial
2012
NCT01698138
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Sunnaas Rehabilitation Hospital, Norway

Active Ingredients

Drugs in Phase 4 Trials (1)

rimabotulinumtoxinB (Myobloc) (1 trial)

Drugs in Phase 1 Trials (1)

melatonin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Quadriplegia (Phase 1)

Spinal Cord Injuries (Phase 4)

Urinary Bladder, Overactive (Phase 4)

Wounds and Injuries (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2